leisure time -WSS

leisure time

author：comprehensive 2025-09-03 09:25:54 - browse：8975

Sammy Kimball for STAT

Is Wegovy really a brain drug? Which Alzheimer’s disease treatment works best? And what’s the point of Threads?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Megan Molteni joins us to explain the evolving science suggesting products like Wegovy are less weight loss drugs than treatments for human desire. We also explain why this summer is shaping up to be a pivotal moment for the treatment of Alzheimer’s and discuss our befuddlement with the latest social media platform.

For more on what we cover, here’s the story on GLP-1 drugs and the brain; here’s the latest on Leqembi; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： U.K. considers world's first use of meningitis vaccine to address gonorrhea

focus

WSS

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Biotech lab space demand falls sharply

Readout LOUD podcast: possible new ALS drug, artificial wombs

Ukraine and a new approach to mental health in war

A daunting task: navigating dual Medicare, Medicaid eligibility

CRISPR pioneers react to Casgevy, first gene

hotspot

leisure time

entertainment

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Poor hospice wound care hurts patients and families

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Biotech stock slump in 2023: awaiting the turnaround

BioMarin wins approval for gene therapy to treat hemophilia A

Hearing on Medicare drug price negotiation gets unusually heated

Wildfire smoke exposes gaps in outdoor worker protections

Surge of respiratory disease in China has likely explanation

Medical records are filled with copy

Surge of respiratory disease in China has likely explanation

focus

Anthos stroke drug appears safer than common blood thinner

CRISPR pioneers react to Casgevy, first gene

Readout LOUD podcast: A CRISPR milestone, biotech mixology

In key trial, Verve's treatment lowers cholesterol levels in patients

Thermo Fisher plant for manufacturing gene therapies to expand

Why medical students are struggling with mental health

focus

Wikipedia

focus

focus